Bioatla Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$3.83

+0.15 (+4.08%)

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +145.4% upside

Low Target $5.45

Average Target $9.40

High Target $11.97

Current Price $3.83

Current
$3.83

Target
$9.40

$5.45 $9.40 avg $11.97

Scenario Analysis

Bear Case

$5.45

42.3%

Low target

Base Case

$9.40

+145.4%

Avg target

Bull Case

$11.97

+212.5%

High target

Risk/Reward

5.0x

Highly favorable

Price in Context

52-Week High

$71.50

-94.6% from high

52-Week Low

$3.12

+22.8% from low

Target vs 52W High

$9.40

-86.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.2%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.5%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.4%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-65.6%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-40.8%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-48.0%